Peng Xiu

1.1k total citations
30 papers, 868 citations indexed

About

Peng Xiu is a scholar working on Cancer Research, Molecular Biology and Oncology. According to data from OpenAlex, Peng Xiu has authored 30 papers receiving a total of 868 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Cancer Research, 13 papers in Molecular Biology and 12 papers in Oncology. Recurrent topics in Peng Xiu's work include Cancer, Hypoxia, and Metabolism (5 papers), Cancer, Lipids, and Metabolism (5 papers) and Hepatocellular Carcinoma Treatment and Prognosis (4 papers). Peng Xiu is often cited by papers focused on Cancer, Hypoxia, and Metabolism (5 papers), Cancer, Lipids, and Metabolism (5 papers) and Hepatocellular Carcinoma Treatment and Prognosis (4 papers). Peng Xiu collaborates with scholars based in China, New Zealand and United States. Peng Xiu's co-authors include Jie Li, Zongzhen Xu, Jingtao Zhong, Fuhai Wang, Honglong Wei, Xueying Sun, Xiaofeng Dong, Feng Liu, Guangsheng Yang and Tao Li and has published in prestigious journals such as PLoS ONE, Hepatology and Scientific Reports.

In The Last Decade

Peng Xiu

29 papers receiving 857 citations

Peers

Countries citing papers authored by Peng Xiu

Since Specialization

Citations

This map shows the geographic impact of Peng Xiu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peng Xiu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peng Xiu more than expected).

Fields of papers citing papers by Peng Xiu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peng Xiu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peng Xiu. The network helps show where Peng Xiu may publish in the future.

Co-authorship network of co-authors of Peng Xiu

This figure shows the co-authorship network connecting the top 25 collaborators of Peng Xiu. A scholar is included among the top collaborators of Peng Xiu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Peng Xiu. Peng Xiu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Comprehensive profiling of lipid metabolic reprogramming expands precision medicine for HCC 2024 ·Hepatology ·(unknown), Xiangyu Zhang, Jingjing Qi, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Yiming Zhang, Lijuan Wang, (unknown), (unknown), (unknown), (unknown), Weiyang Li, Peng Xiu, (unknown), Yong Yu, Shulong Jiang	19
2	The clinical significance of microvascular invasion in the surgical planning and postoperative sequential treatment in hepatocellular carcinoma 2021 ·Scientific Reports ·Wentao Wang, (unknown), Jingtao Zhong, Qi Wang, Xin Wang, Honglong Wei, Jie Li, Peng Xiu	53
3	Meloxicam, a Selective COX-2 Inhibitor, Mediates Hypoxia-Inducible Factor- (HIF-) 1α Signaling in Hepatocellular Carcinoma 2020 ·Oxidative Medicine and Cellular Longevity ·(unknown), Xiaofeng Dong, Peng Xiu, (unknown), Jianrong Yang, Lei Li, (unknown), Pengfei Sun, Xuetao Shi, Jingtao Zhong	16
4	Integrated miRNAome and mRNAome analysis identifies candidate genes that mediate testis development promoted by vitamin E in sheep 2020 ·Animal Science Papers and Reports ·Yan Gao, Wenhan Lu, Yue Qu, (unknown), (unknown), Peng Xiu, Zoltán Macháty, Hanpeng Luo	2
5	Triplet Male Lambs Are More Susceptible than Twins to Dietary Soybean Oil–Induced Fatty Liver 2019 ·Journal of Nutrition ·Bo Wang, (unknown), Yiping Wang, (unknown), Chenchen Xu, Fadi Li, Ce Liu, (unknown), Peng Xiu, Yuefeng Gao, (unknown), Yuxia Li, Hailing Luo	0
6	T7 peptide cytotoxicity in human hepatocellular carcinoma cells is mediated by suppression of autophagy 2019 ·International Journal of Molecular Medicine ·Feng Liu, Fuhai Wang, Xiaofeng Dong, Peng Xiu, Pengfei Sun, (unknown), Xuetao Shi, Jingtao Zhong	11
7	Sodium orthovanadate overcomes sorafenib resistance of hepatocellular carcinoma cells by inhibiting Na+/K+-ATPase activity and hypoxia-inducible pathways 2018 ·Scientific Reports ·Wenjing Jiang, Guangxin Li, Weidong Li, Ping Wang, Peng Xiu, Xian Jiang, Bing Liu, Xueying Sun, Hongchi Jiang	26
8	Human translation vs machine translation: The practitioner phenomenology 2018 ·Linguistics and Culture Review ·Peng Xiu, (unknown)	2
9	Human translation vs machine translation: The practitioner phenomenology 2018 ·Linguistics and Culture Review ·Peng Xiu, (unknown)	6
10	Secretory Clusterin Mediates Oxaliplatin Resistance via the Gadd45a/PI3K/Akt Signaling Pathway in Hepatocellular Carcinoma 2018 ·Journal of Cancer ·Xin Wang, (unknown), Jingtao Zhong, Long-Tao Yue, Fuhai Wang, Honglong Wei, Guangsheng Yang, Jin Tao, Xiaofeng Dong, Jie Li, Peng Xiu	26
11	Clinical applications of liquid biopsy as prognostic and predictive biomarkers in hepatocellular carcinoma: circulating tumor cells and circulating tumor DNA 2018 ·Journal of Experimental & Clinical Cancer Research ·Jie Li, (unknown), Xiaona Yu, Zongzhen Xu, Guangsheng Yang, Bingqi Liu, Peng Xiu	88
12	P18 peptide, a functional fragment of pigment epithelial-derived factor, inhibits angiogenesis in hepatocellular carcinoma via modulating VEGF/VEGFR2 signalling pathway 2017 ·Oncology Reports ·Xin Wang, Peng Xiu, Fuhai Wang, Jingtao Zhong, Honglong Wei, Zongzhen Xu, Feng Liu, Jie Li	16
13	Meloxicam suppresses hepatocellular carcinoma cell proliferation and migration by targeting COX-2/PGE2-regulated activation of the β-catenin signaling pathway 2016 ·Oncology Reports ·Tao Li, Jingtao Zhong, Xiaofeng Dong, Peng Xiu, Fuhai Wang, Honglong Wei, Xin Wang, Zongzhen Xu, Feng Liu, Xueying Sun, Jie Li	28
14	An asymmetrically dimethylarginated nuclear 90 kDa protein (p90aDMA) induced by interleukin (IL)-2, IL-4 or IL-6 in the tumor microenvironment is selectively degraded by autophagy 2016 ·International Journal of Oncology ·Lei Sun, (unknown), Shaohua Zhao, Ning Liu, Shanshan Liu, Peng Xiu, Linfeng Li, Xuelei Cao, Jianxin Gao	4
15	Targeting hypoxia-inducible factor-2α enhances sorafenib antitumor activity via β-catenin/C-Myc-dependent pathways in hepatocellular carcinoma 2015 ·Oncology Letters ·Feng Liu, Xiaofeng Dong, Hong Lv, Peng Xiu, (unknown), Fuhai Wang, Zongzhen Xu, Jie Li	32
16	Meloxicam Executes Its Antitumor Effects against Hepatocellular Carcinoma in COX-2- Dependent and -Independent Pathways 2014 ·PLoS ONE ·Xiaofeng Dong, Rui Li, Peng Xiu, Xuesong Dong, Zongzhen Xu, Bo Zhai, Feng Liu, Hongchi Jiang, Xueying Sun, Jie Li, Haiquan Qiao	39
17	Integrin αvβ3 is required for cathepsin B-induced hepatocellular carcinoma progression 2014 ·Molecular Medicine Reports ·Zongzhen Xu, Peng Xiu, (unknown), Fuhai Wang, Xiaofeng Dong, Feng Liu, Tao Li, Jie Li	24
18	Downregulating sCLU Enhances the Sensitivity of Hepatocellular Carcinoma Cells to Gemcitabine by Activating the Intrinsic Apoptosis Pathway 2014 ·Digestive Diseases and Sciences ·Peng Xiu, Zongzhen Xu, Feng Liu, Ziqiang Li, Tao Li, (unknown), Xueying Sun, Jie Li	16
19	Clozapine directly increases insulin and glucagon secretion from islets: Implications for impairment of glucose tolerance 2014 ·Schizophrenia Research ·Greg C. Smith, Z.Y. Zhang, (unknown), Natalia Petersen, (unknown), Peng Xiu, Anthony R.J. Phillips, Weiping Han, (unknown), Peter R. Shepherd	21
20	Secretory clusterin contributes to oxaliplatin resistance by activating Akt pathway in hepatocellular carcinoma 2012 ·Cancer Science ·Peng Xiu, Xuesong Dong, Xiaofeng Dong, Zongzhen Xu, Huaqiang Zhu, Feng Liu, Zheng Wei, Bo Zhai, Jagat R. Kanwar, Hongchi Jiang, Jie Li, Xueying Sun	57

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact